Correlation Between GH Research and Biovaxys Technology

Can any of the company-specific risk be diversified away by investing in both GH Research and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GH Research PLC and Biovaxys Technology Corp, you can compare the effects of market volatilities on GH Research and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and Biovaxys Technology.

Diversification Opportunities for GH Research and Biovaxys Technology

0.07

Correlation Coefficient

GH Research  Biovaxys Technology

Significant diversification

The 3 months correlation between GHRS and Biovaxys is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of GH Research i.e., GH Research and Biovaxys Technology go up and down completely randomly.

Pair Corralation between GH Research and Biovaxys Technology

Given the investment horizon of 90 days GH Research PLC is expected to generate 0.68 times more return on investment than Biovaxys Technology. However, GH Research PLC is 1.46 times less risky than Biovaxys Technology. It trades about 0.02 of its potential returns per unit of risk. Biovaxys Technology Corp is currently generating about -0.02 per unit of risk. If you would invest  911.00  in GH Research PLC on October 26, 2024 and sell it today you would lose (11.00) from holding GH Research PLC or give up 1.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	97.5%
Values	Daily Returns

GH Research PLC  vs.  Biovaxys Technology Corp

GH Research PLC

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research unveiled solid returns over the last few months and may actually be approaching a breakup point.

Biovaxys Technology Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biovaxys Technology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with GH Research and Biovaxys Technology

The main advantage of trading using opposite GH Research and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.

The idea behind GH Research PLC and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.